GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for breast cancer anti-estrogen resistance protein 3 homolog (Q6INP9)

Analyse AlphaFold monomer V2.0 prediction for breast cancer anti-estrogen resistance… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q6INP9
Type
protein
Length
806 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x9e5E98E011361C5888c92e2CDb7652E02Bd5C7Ed
Molecule
Breast cancer anti-estrogen resistance protein 3 homolog
UniProt
Q6INP9
Pockets
8 · best druggability 0.79

Structure

1 distinct chain · 31% helix, 6% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABreast cancer anti-estrogen resistance protein 3 homologprotein80631% helix, 6% strandQ6INP9

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11620.790.9430empty
23270.660.8139empty
31650.620.8429empty
41700.470.7626empty
51550.470.7717empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.